12/17/2024
5:03 PM | CG Oncology (Issuer)
Song Hong Fang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
11:15 PM | CG Oncology (Filer)
| Form EFFECT | |
12/11/2024
3:09 PM | CG Oncology (Filer)
| Form S-1/A | |
12/11/2024
5:06 AM | CG Oncology (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/06/2024
5:51 PM | CG Oncology (Issuer)
POST LEONARD E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
6:52 AM | CG Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
1:30 PM | CG Oncology (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
|
11/04/2024
9:22 AM | CG Oncology (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
CG Oncology (Subject)
| Form SC 13G | |
10/08/2024
8:29 AM | CG Oncology (Issuer)
Roche Corleen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:17 PM | CG Oncology (Issuer)
POST LEONARD E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
3:51 PM | CG Oncology (Issuer)
Kuan Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
3:56 PM | CG Oncology (Issuer)
Patterson Joshua F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:00 PM | Bellete Ambaw (Reporting)
CG Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:00 PM | CG Oncology (Issuer)
Mulay James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:03 PM | CG Oncology (Issuer)
Song Hong Fang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:07 PM | CG Oncology (Issuer)
Kasturi Vijay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:07 PM | CG Oncology (Issuer)
Tong Victor Edward Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:08 PM | CG Oncology (Issuer)
Liu Brian Guan-Chyun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:09 PM | CG Oncology (Issuer)
Graf Susan E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
6:18 PM | CG Oncology (Issuer)
Song Hong Fang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
7:26 PM | CG Oncology (Subject)
Charming Jade Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
7:27 PM | CG Oncology (Subject)
Unique Diamond Investments Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
5:43 PM | CG Oncology (Subject)
Charming Jade Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
5:44 PM | CG Oncology (Subject)
Unique Diamond Investments Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
5:19 AM | CG Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
5:19 AM | CG Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/22/2024
3:35 PM | CG Oncology (Subject)
Unique Diamond Investments Ltd (Filed by)
| Form SC 13G | |
05/24/2024
7:15 AM | CG Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
5:57 PM | CG Oncology (Issuer)
Patterson Joshua F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
4:11 PM | CG Oncology (Issuer)
Patterson Joshua F. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/09/2024
7:10 AM | CG Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
5:07 AM | CG Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/09/2024
6:08 PM | CG Oncology (Issuer)
Cui Xiangmin (Reporting)
Decheng Capital Global Healthcare Fund , LP (0001949026) (Reporting)
Decheng Capital Global Healthcare GP, LLC (Reporting)
Decheng Capital Global Life Sciences Fund IV, L.P. (Reporting)
| Form 4/A | |
04/09/2024
6:12 PM | CG Oncology (Subject)
Decheng Capital Global Life Sciences Fund IV, L.P. (Filed by)
| Form SC 13G/A | |
03/26/2024
5:05 AM | CG Oncology (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2024
6:25 PM | CG Oncology (Subject)
Kissei Pharmaceutical Co., Ltd. (Filed by)
| Form SC 13G | |
02/16/2024
3:21 PM | CG Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
3:31 PM | CG Oncology (Subject)
TCG Crossover GP I, LLC (Filed by)
| Form SC 13G | |
02/08/2024
4:17 PM | CG Oncology (Subject)
Decheng Capital Global Life Sciences Fund IV, L.P. (Filed by)
| Form SC 13G | |
02/05/2024
3:40 PM | CG Oncology (Subject)
Longitude Capital Partners IV, LLC (Filed by)
| Form SC 13G | |
$20k in extra income? (Ad) My friend Alex Reid just might have created my favorite strategy right now.
You see, Alex has figured out how to cut-the-corner so to speak, and be one of the laziest traders possible….
While still showing his traders how to target big money.
This past year, his LIVE “lazy trade” alerts have delivered impressive results—and that’s only a fraction of the opportunities he’s shared.
And that’s just just a quarter of the total trade alerts he’s sent out.
The true total profit potential his beta-testers have had the chance to target is far larger than $20k.  Alex recorded a special video training where he reveals exactly how much. |
02/05/2024
2:15 PM | CG Oncology (Subject)
Foresite Capital Fund V, L.P. (Filed by)
| Form SC 13G | |
01/31/2024
3:30 PM | CG Oncology (Issuer)
Song Hong Fang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:30 PM | CG Oncology (Issuer)
Roche Corleen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:30 PM | CG Oncology (Issuer)
Kasturi Vijay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
6:10 AM | CG Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
4:12 PM | CG Oncology (Filer)
| Form 424B4 | |
01/24/2024
11:15 PM | CG Oncology (Filer)
| Form EFFECT | |
01/24/2024
8:01 PM | CG Oncology (Issuer)
Charming Jade Ltd (Reporting)
Healthcare Seed Ltd (Reporting)
ORI Capital Holding Inc. (Reporting)
ORI Capital II Inc. (Reporting)
ORI Capital Inc. (Reporting)
ORI Healthcare Fund II, L.P. (Reporting)
ORI Healthcare Fund, L.P. (Reporting)
Song Hong Fang (Reporting)
Unique Diamond Investments Ltd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/24/2024
8:03 PM | CG Oncology (Issuer)
Roche Corleen M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/24/2024
8:05 PM | CG Oncology (Issuer)
Kuan Arthur (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/24/2024
8:11 PM | Bellete Ambaw (Reporting)
CG Oncology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/24/2024
8:15 PM | CG Oncology (Issuer)
Liu Brian Guan-Chyun (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/24/2024
7:47 PM | CG Oncology (Issuer)
Mulay James (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/24/2024
7:54 PM | CG Oncology (Issuer)
Tong Victor Edward Jr (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/24/2024
7:55 PM | CG Oncology (Issuer)
Graf Susan E (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/24/2024
7:55 PM | CG Oncology (Issuer)
Kasturi Vijay (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/24/2024
7:56 PM | CG Oncology (Issuer)
POST LEONARD E (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/24/2024
7:26 PM | CG Oncology (Issuer)
Cui Xiangmin (Reporting)
Decheng Capital Global Life Sciences Fund IV, L.P. (Reporting)
Decheng Capital Management IV , LLC (0001843384) (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/24/2024
5:53 PM | CG Oncology (Filer)
| Form S-1MEF | |
01/24/2024
8:34 AM | CG Oncology (Filer)
| Form CERT | |
01/23/2024
5:06 AM | CG Oncology (Filer)
| Form S-1/A | |
01/22/2024
3:57 PM | CG Oncology (Filer)
| Form 8-A12B | |
01/18/2024
5:04 AM | CG Oncology (Filer)
| Form S-1/A | |
01/02/2024
4:16 PM | CG Oncology (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
